{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:10:17Z","timestamp":1767179417442,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013112","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000}}],"reference-count":7,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Task Force for Global Health","award":["188D"],"award-info":[{"award-number":["188D"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Lymphatic filariasis (LF), commonly called \u201celephantiasis,\u201d is one of the leading causes of disability around the world, with approximately 863 million people across 47 countries still living under threat of LF infection. India, with 40% of the global LF burden, is the most affected country that undertakes annual mass drug administration (MDA) using double and triple drug chemoprophylaxis in 157 LF-endemic districts. Consumption of drugs during MDA campaigns remains the biggest challenge for disease elimination in the country. PATH conducted a dual-phased study titled, \u201cA Mixed-Method Study to Improve outcome of Mass Drug Administration in Two TAS failed Districts of Uttar Pradesh, India.\u201d The study aimed to identify the critical factors in achieving optimal drug consumption among community members during MDA campaigns (pre-intervention phase), develop an intervention package (IP) for use in the\u00a0government's\u00a0subsequent MDA program to improve the coverage, and assess the impact (post-intervention phase). The quantitative data collection entailed house-to-house and drug administrator surveys, while qualitative data collection included in-depth interviews and rapid ethnography. The main reason for\u00a0non-consumption was found to be fear of side effects, followed by away from home, lack of awareness, and suboptimal\u00a0micro-planning. Post-IP measurements showed that there was an increase in evaluated coverage of 10.1% in Varanasi and 20.7% in Chitrakoot, as well as an increase in community awareness of 40% in Chitrakoot, with interpersonal communication being the most effective method for demand generation\/ community awareness. An Intervention Package (IP), developed and piloted in the two study districts, was adopted by the state government of Uttar Pradesh and used across all 50 LF-endemic districts in the state.<\/jats:p>","DOI":"10.1371\/journal.pntd.0013112","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T14:00:43Z","timestamp":1751896843000},"page":"e0013112","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["A mixed-method study to improve outcome of mass drug administration in two TAS failed districts of Uttar Pradesh, India"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0570-4448","authenticated-orcid":true,"given":"Achintya","family":"Srivatsa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padmalochan","family":"Biswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyabrata","family":"Routray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Bardosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurpit","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoaib","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vindu Prakash","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"pntd.0013112.ref001","volume-title":"Elimination of lymphatic filariasis as a public health problem","author":"World Health Assembly, 50","year":"1997"},{"key":"pntd.0013112.ref002","volume-title":"Guidelines on elimination of lymphatic filariais India","author":"Directorate of National Vector Borne Disease Control Programme","year":"2009"},{"issue":"9","key":"pntd.0013112.ref003","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/trstmh\/tru057","article-title":"Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review","volume":"108","author":"BV Babu","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0013112.ref004","volume-title":"Elimination of lymphatic filariasis 2013-14: national guidelines for Transmission Assessment Survey","author":"Directorate of National Vector Borne Disease Control Programme"},{"key":"pntd.0013112.ref005","doi-asserted-by":"crossref","DOI":"10.1002\/0471445428","volume-title":"Statistical Methods for Rates and Proportions","author":"JL Fleiss","year":"2003"},{"issue":"2","key":"pntd.0013112.ref006","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/JVBD.JVBD_102_24","article-title":"Coverage and evaluation survey of post-mass drug administration for lymphatic filariasis in four endemic districts of Uttar Pradesh: Are we on the track?","volume":"62","author":"S Paul","year":"2025","journal-title":"J Vector Borne Dis"},{"issue":"3","key":"pntd.0013112.ref007","first-page":"1454","article-title":"An evaluation study in Prayagraj district reported significant gaps in MDA drug consumption between urban and rural areas, citing fear of side effects as a major factor","volume":"8","author":"S Ram","year":"2021","journal-title":"Int J Community Med Public Health"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013112","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T18:05:28Z","timestamp":1752257128000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013112"}},"subtitle":[],"editor":[{"given":"Amit Kumar","family":"Mandal","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":7,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013112","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]}}}